Literature DB >> 30802611

Analytical methods and biological activities of Panax notoginseng saponins: Recent trends.

Congcong Xu1, Weiwei Wang1, Bing Wang2, Tong Zhang1, Xiuming Cui3, Yiqiong Pu4, Ning Li5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Panax notoginseng (Burk.) F. H. Chen, also called Sanqi, is a widely used traditional Chinese medicine, which has long history used as herbal medicines. It is currently an important medicinal material in China, holding the first place in the sale volume of the whole patent medicines market in China, and the market size of the single species has exceeded 10 billion yuan. In addition, P. notoginseng is an important constituent part of many famous Chinese patent medicines, such as Compound Danshen Dripping Pills and Yunnan Baiyao. P. notoginseng saponins (PNSs), which are the major active components of P. notoginseng, are a kind of chemical mixture containing different dammarane-type saponins. Many studies show that PNSs have been extensively used in medical research or applications, such as atherosclerosis, diabetes, acute lung injury, cancer, and cardiovascular diseases. In addition, various PNS preparations, such as injections and capsules, have been made commercially available and are widely applied in clinical practice. AIM OF THE REVIEW: Since the safety and efficacy of compounds are related to their qualitative and quantitative analyses, this review briefly summarizes the analytic approaches for PNSs and their biological effects developed in the last decade.
METHODOLOGY: This review conducted a systematic search in electronic databases, such as Pubmed, Google Scholar, SciFinder, ISI Web of Science, and CNKI, since 2009. The information provided in this review is based on peer-reviewed papers and patents in either English or Chinese.
RESULTS: At present, the chromatographic technique remains the most extensively used approach for the identification or quantitation of PNSs, coupled with different detectors, among which the difference mainly lies in their sensitivity and specificity for analyzing various compounds. It is well-known that PNSs have traditionally strong activity on cardiovascular diseases, such as atherosclerosis, intracerebral hemorrhage, or brain injury. The recent studies showed that PNSs also responded to osteoporosis, cancers, diabetes, and drug toxicity. However, some other studies also showed that some PNSs injections and special PNS components might lead to some biological toxicity under certain dosages.
CONCLUSION: This review may be used as a basis for further research in the field of quantitative and qualitative analyses, and is expected to provide updated and valuable insights into the potential medicinal applications of PNSs.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Analysis; HPLC; Panax notoginseng; Pharmacology; Toxicity

Mesh:

Substances:

Year:  2019        PMID: 30802611     DOI: 10.1016/j.jep.2019.02.035

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  29 in total

Review 1.  Natural Antioxidants Improve the Vulnerability of Cardiomyocytes and Vascular Endothelial Cells under Stress Conditions: A Focus on Mitochondrial Quality Control.

Authors:  Xing Chang; Zhenyu Zhao; Wenjin Zhang; Dong Liu; Chunxia Ma; Tian Zhang; Qingyan Meng; Peizheng Yan; Longqiong Zou; Ming Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-01-22       Impact factor: 6.543

2.  Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway.

Authors:  Wei Lei; Yiqi Yan; Yaolei Ma; Min Jiang; Boli Zhang; Han Zhang; Yuhong Li
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

3.  Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus.

Authors:  Xiao-Yan Cui; Xiao Wu; Dan Lu; Dan Wang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

4.  Effect of Shuangdan Mingmu Capsule on Diabetic Retinopathy in Rats via Regulation of miRNAs.

Authors:  Xiang Li; Yijing Yang; Yan Song; Fujiao Nie; Chaojun Fu; Yuhui Qin
Journal:  Diabetes Metab Syndr Obes       Date:  2022-10-19       Impact factor: 3.249

5.  Muscle Fatigue-Alleviating Effects of a Prescription Composed of Polygonati Rhizoma and Notoginseng Radix et Rhizoma.

Authors:  Ya-Qin Yang; Yan-Qin Li; Li-Ping Yu; Xue Li; Jian-Kang Mu; Jin Shang; Wen Gu; Jing-Ping Li; Jie Yu; Xing-Xin Yang
Journal:  Biomed Res Int       Date:  2020-06-08       Impact factor: 3.411

6.  Panax notoginseng saponins promote liver regeneration through activation of the PI3K/AKT/mTOR cell proliferation pathway and upregulation of the AKT/Bad cell survival pathway in mice.

Authors:  Hua Zhong; Hao Wu; He Bai; Menghao Wang; Jian Wen; Jianping Gong; Mingyong Miao; Fangchao Yuan
Journal:  BMC Complement Altern Med       Date:  2019-06-10       Impact factor: 3.659

7.  Antithrombotic effect and action mechanism of Salvia miltiorrhiza and Panax notoginseng herbal pair on the zebrafish.

Authors:  Shi-Jun Yin; Ying-Qing Luo; Cong-Peng Zhao; Hua Chen; Zhang-Feng Zhong; Shengpeng Wang; Yi-Tao Wang; Feng-Qing Yang
Journal:  Chin Med       Date:  2020-04-16       Impact factor: 5.455

Review 8.  New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach.

Authors:  Yanfei Liu; Weiliang Weng; Rui Gao; Yue Liu
Journal:  Oxid Med Cell Longev       Date:  2019-12-12       Impact factor: 6.543

9.  New Dammarane-Type Triterpenoid Saponins from Panax notoginseng Leaves and Their Nitric Oxide Inhibitory Activities.

Authors:  Fan Sun; Jingya Ruan; Wei Zhao; Ying Zhang; Guilin Xiang; Jiejing Yan; Mimi Hao; Lijie Wu; Yi Zhang; Tao Wang
Journal:  Molecules       Date:  2019-12-29       Impact factor: 4.411

10.  Panax Notoginseng Saponins Protect H9c2 Cells From Hypoxia-reoxygenation Injury Through the Forkhead Box O3a Hypoxia-inducible Factor-1 Alpha Cell Signaling Pathway.

Authors:  Xin-Wen Liu; Meng-Kai Lu; Hui-Ting Zhong; Jing-Jing Liu; Yong-Ping Fu
Journal:  J Cardiovasc Pharmacol       Date:  2021-08-05       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.